Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
9.42M
-
Shares change
-
+916K
-
Total reported value, excl. options
-
$329M
-
Value change
-
+$38.1M
-
Put/Call ratio
-
0.15
-
Number of buys
-
63
-
Number of sells
-
-59
-
Price
-
$34.91
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q1 2018
140 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q1 2018.
Medpace Holdings, Inc. - Common Stock (MEDP) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.42M shares
of 30.9M outstanding shares and own 30.51% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.24M shares), BlackRock Inc. (1.21M shares), ACADIAN ASSET MANAGEMENT LLC (999K shares), BERNZOTT CAPITAL ADVISORS (692K shares), AMERIPRISE FINANCIAL INC (626K shares), UBS Group AG (323K shares), Man Group plc (280K shares), Granite Investment Partners, LLC (260K shares), STATE STREET CORP (226K shares), and PRUDENTIAL FINANCIAL INC (177K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.